Relapsing fever, epidemicA68.0

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Epidemic relapsing fever; Louseborne relapsing Fever; Relapsing fever epidemic; relapsing lice fever

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

HistoryThis section has been translated automatically.

Rutty 1770; Craigie 1843; Obermeier 1873

DefinitionThis section has been translated automatically.

Notifiable, severe infectious disease caused by Borrelia bacteria, transmitted from person to person by lice ( Pediculosis corporis) with typical fever attacks as in endemic relapsing fever. Relapses in 30% of cases.

PathogenThis section has been translated automatically.

Borrelia recurrentis. Pathogen reservoir: human. Carrier: Pediculus humanus corporis.

Occurrence/EpidemiologyThis section has been translated automatically.

Asia, East Africa, Ethiopia, Sudan, North and Central Africa, South America. In Europe, increasingly introduced by migrants, occurring (Bloch-Infanger C et al.; Ciervo A et al.).

Clinical featuresThis section has been translated automatically.

Incubation period 2-10 days. Acute onset of high fever (40-41 °C), headache, joint and muscle pain, abdominal pain, stiff neck, photophobia, splenomegaly, hepatomegaly, icterus, exanthema. The first fever period lasts about 6 days followed by a fever-free interval of about 8-10 days. Usually 2-6 further fever spurts occur in the further course of the disease. Massive bacteremia and infestation of almost all organs.0

The fever attacks decrease in severity in uncomplicated courses. Immunity up to 1 year after infection.

Complicated myocarditis can lead to death, as can disseminated intravascular coagulation.

LaboratoryThis section has been translated automatically.

Pathogen detection in the blood (smear, thick drop, dark field microscopy). Serology (ELISA, CFT, agglutination). If necessary, detection in animal experiments.

Complication(s)This section has been translated automatically.

Myocarditis (possibly life-threatening), nephritis, liver failure and adult respiratory distress syndrome, severe bleeding tendencies (epistaxis, conjunctival bleeding, gastrointestinal haemorrhages).

TherapyThis section has been translated automatically.

  • Benzylpenicillin (e.g. penicillin Grünenthal) 20 million IU/day i.v. over 14 days. Cave! Herxheimer reaction.
  • Alternatively: Doxycycline (e.g. Doxycycline 100 Heumann) 2 times/day 100 mg or Tetracycline (e.g. Tetracycline Wolff Kps.) 3-4 times/day 500 mg p.o. over 14 days.

Progression/forecastThis section has been translated automatically.

If left untreated, it is often lethal (about 50% of cases).

ProphylaxisThis section has been translated automatically.

Lice control. S.u. Pediculosis corporis.

LiteratureThis section has been translated automatically.

  1. Bloch-Infanger C et al(2017) Increasing prevalence of infectious diseases in asylum seekers at a tertiary care hospital in Switzerland. PLoS One 12:e0179537.
  2. Ciervo A et al (2016) Louseborne Relapsing Fever in Young Migrants, Sicily, Italy, July-September 2015, Emerg Infect Dis 22:152-153.
  3. Lucchini A et al. (2016) Louseborne Relapsing Fever among East African Refugees, Italy, 2015; Emerg Infect Dis 22:298-301.

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer